COVID-19 Policy for Blood Cancer and BMT Hospital and Clinic Visitation
Research Medical Center and our Blood and Marrow Transplant (BMT) and Blood Cancer programs at our Sarah Cannon Cancer Center place the highest priority on the health and safety of our patients, staff and caregivers. Due to the presence of Coronavirus/COVID-19 in our community, we are taking measures to protect our patients with compromised immune systems. Entrances to our hospital and clinic are limited to allow for effective screening of patients and visitors. You may enter the hospital through the hospital patient registration entrance, the main lobby (visitor entrance) and the Sarah Cannon Cancer Center entrance.
Hospital Visitation Policy for Blood Cancer and BMT Units
No visitors are allowed to enter the Blood Cancer and BMT Units for the protection of our immunosuppressed patients.
We encourage phone calls, FaceTime or other video/virtual interactions with family and friends.
Blood Cancer and BMT Clinic
No visitors are allowed in the clinic. An exception for one visitor may be requested by the physician for specific circumstances but must be approved by clinic leadership. Screening prior to the appointment will include questions re: recent travel, exposure to ill individuals, cough, fever, or other symptoms, and taking the patient’s (and visitor’s) temperature.
We will continue to keep all patients and visitors updated on the screening processes during this time.
For clinic appointments, it is best to park in Visitor Parking Lot B and enter through the Sarah Cannon Cancer Center entrance.
What are the symptoms of COVID-19 infection?
- Shortness of breath
What can I do to protect myself and others?
Public health officials recommend the following steps to help prevent the spread of respiratory viruses, including influenza and COVID-19:
- Avoid close contact with people who are sick
- Avoid touching your eyes, nose, and mouth
- Stay home when you are sick
- Cover your cough or sneeze with a tissue
- Practice good hand hygiene by washing your hands often, using either soap and water or alcohol-based hand gel for at least 20 seconds
- Clean and disinfect frequently-touched objects and surfaces
For additional information and ongoing updates on COVID-19, please refer to local and state health departments and the CDC’s Coronavirus Disease 2019 (COVID-19) hub.
Sarah Cannon Blood Cancer Center at Research Medical Center
The Sarah Cannon Blood Cancer Center at Research Medical Center provides specialized care for acute leukemia and complex blood cancer patients. The program provides comprehensive outpatient services and a dedicated inpatient oncology unit supported by a multidisciplinary team of specialists and staffed by oncology nurses.
The specialists at the Sarah Cannon Blood Cancer Center offer the latest advancements in treatment including clinical trials, immunotherapies and blood and marrow transplants (BMT) (otherwise known as stem cell transplants or bone marrow transplants) from nationally renowned Sarah Cannon, one of the leading providers of blood and marrow transplants in the world.
Why Choose the Sarah Cannon Blood Cancer Center at Research Medical Center
- More patients in the Kansas City metro area choose Sarah Cannon Blood Cancer Network than any other center
- Patients will have a dedicated oncology-trained nurse navigator to walk them through every step of their blood cancer journey
- Our physicians are able to connect with Sarah Cannon blood cancer experts across the network to discuss cases and develop the best treatment plans
- All of our registered nurses are chemotherapy certified after one year of employment and a nurse manger or charge nurse rounds on patients daily to ensure exceptional patient care
- Through Sarah Cannon, patients have access to cancer wellness resources including nutrition, psycho-social care, rehab services, and survivorship support
Types of Blood Cancer We Treat
- Acute Lymphocytic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Hodgkin Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndrome (MDS)
- Non-Hodgkin Lymphoma (NHL)
Sarah Cannon Blood Cancer Network
By joining the Sarah Cannon Blood Cancer Network, the Sarah Cannon Blood Cancer Center at Research Medical Center made the commitment to work with the other programs in the Network to standardize our quality platform, infrastructure, training and research to provide an unparalleled experience for patients seeking treatment for blood cancer. The clinical and operational efficiencies inherent in standardization and coordination of capabilities make the Sarah Cannon Blood Cancer Network well-positioned to provide quality care while demonstrating superior value.
Blood and Marrow Transplant (BMT) (also known as Stem Cell Transplant)
A blood and marrow transplant may be recommended for patients with blood cancer.
Blood and marrow transplants are sometimes also called stem cell transplants or bone marrow transplants. In the past, stem cells were collected from the bone marrow, the soft, spongy tissue inside bones, hence the name “bone marrow transplant.” Recent technology now allows stem cells to be collected from blood.
There are various types of blood and marrow transplants. All types involve hematopoietic stem cells, a kind of cell that can mature into healthy blood cells.
The Sarah Cannon Blood Cancer Center at Research Medical Center offers:
- Autologous transplants – A stem cell transplant where a patient serves as his or her own donor
During an autologous transplant:
- A patient’s cancer team will collect stem cells from their blood via a process called apheresis. During this process their blood is circulated through a machine where stem cells are gathered and the remaining blood is returned to their body. The stem cells are sent to a lab where they are tested and frozen.
- The patient will likely go through chemotherapy treatment (or possibly radiation) to treat the blood cancer.
- The patient’s hematologist will perform the stem cell infusion.
- For the next few weeks, the patient will be under close observation. Their blood counts will be monitored and will be check to make sure they are healthy and doing well.
The stem cells will be infused back into the blood through an IV. As the cells go back into the bloodstream, they migrate into the bone marrow. Once in the bone marrow, the stem cells replicate and become healthy red blood cells, platelets or white blood cells.
Oncology Alert Patient Care Program
Sarah Cannon Cancer Institute at HCA Midwest Health offers an Oncology Alert Patient Care Program, the only program in the region that focuses on promptly identifying and treating immunocompromised oncology patients arriving through the cancer clinic or the Emergency Room. The program provides special training to ER and clinic staff to identify and address the unique needs of chemotherapy patients.